These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 30871664)
1. Risk factors for unfavourable treatment outcomes among rifampicin-resistant tuberculosis patients in Tajikistan. Makhmudova M; Maxsumova Z; Rajabzoda A; Makhmadov A; van den Hof S; Mirtskhulava V Int J Tuberc Lung Dis; 2019 Mar; 23(3):331-336. PubMed ID: 30871664 [TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China. Alene KA; Yi H; Viney K; McBryde ES; Yang K; Bai L; Gray DJ; Clements ACA; Xu Z BMC Infect Dis; 2017 Aug; 17(1):573. PubMed ID: 28814276 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study. Guglielmetti L; Veziris N; Aubry A; Brossier F; Bernard C; Sougakoff W; Jarlier V; Robert J Int J Tuberc Lung Dis; 2018 Jan; 22(1):54-59. PubMed ID: 29297426 [TBL] [Abstract][Full Text] [Related]
4. Isoniazid mono-resistant tuberculosis: Time to take it seriously. Garg K; Saini V; Dhillon R; Agarwal P Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492 [TBL] [Abstract][Full Text] [Related]
5. Prevalence, associated factors, outcomes and transmission of extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in São Paulo, Brazil: a cross-sectional study. Gallo JF; Pinhata JMW; Simonsen V; Galesi VMN; Ferrazoli L; Oliveira RS Clin Microbiol Infect; 2018 Aug; 24(8):889-895. PubMed ID: 29175351 [TBL] [Abstract][Full Text] [Related]
7. Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance. Ei PW; Aung WW; Nyunt WW; Swe TL; Htwe MM; Win SM; Aung ST; Chang CL; Lee HY; Lee JS Int J Tuberc Lung Dis; 2018 Jan; 22(1):47-53. PubMed ID: 29297425 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study. Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741 [TBL] [Abstract][Full Text] [Related]
9. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis. Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131 [TBL] [Abstract][Full Text] [Related]
10. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing. Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132 [TBL] [Abstract][Full Text] [Related]
11. The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia. Shibabaw A; Gelaw B; Gebreyes W; Robinson R; Wang SH; Tessema B PLoS One; 2020; 15(2):e0229040. PubMed ID: 32053661 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of pulmonary MDR-TB: impacts of fluoroquinolone resistance and linezolid treatment. Jeong BH; Jeon K; Park HY; Kwon OJ; Lee KS; Kim HK; Choi YS; Kim J; Huh HJ; Lee NY; Koh WJ J Antimicrob Chemother; 2015 Nov; 70(11):3127-33. PubMed ID: 26203184 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of bedaquiline-containing regimens for treatment on patients with refractory RR/MDR/XDR-tuberculosis: a retrospective cohort study in East China. Zhang SJ; Yang Y; Sun WW; Zhang ZS; Xiao HP; Li YP; Zhang ZM; Fan L BMC Infect Dis; 2022 Aug; 22(1):715. PubMed ID: 36038829 [TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154 [TBL] [Abstract][Full Text] [Related]
16. Evidence-based Definition for Extensively Drug-Resistant Tuberculosis. Roelens M; Battista Migliori G; Rozanova L; Estill J; Campbell JR; Cegielski JP; Tiberi S; Palmero D; Fox GJ; Guglielmetti L; Sotgiu G; Brust JCM; Bang D; Lienhardt C; Lange C; Menzies D; Keiser O; Raviglione M Am J Respir Crit Care Med; 2021 Sep; 204(6):713-722. PubMed ID: 34107231 [No Abstract] [Full Text] [Related]
17. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380 [TBL] [Abstract][Full Text] [Related]